FR8293M - - Google Patents

Info

Publication number
FR8293M
FR8293M FR154662A FR154662A FR8293M FR 8293 M FR8293 M FR 8293M FR 154662 A FR154662 A FR 154662A FR 154662 A FR154662 A FR 154662A FR 8293 M FR8293 M FR 8293M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR154662A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR8293M publication Critical patent/FR8293M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR154662A 1967-06-01 1968-06-12 Expired FR8293M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2542567 1967-06-01

Publications (1)

Publication Number Publication Date
FR8293M true FR8293M (fr) 1970-11-16

Family

ID=10227457

Family Applications (1)

Application Number Title Priority Date Filing Date
FR154662A Expired FR8293M (fr) 1967-06-01 1968-06-12

Country Status (2)

Country Link
DE (1) DE1770537A1 (fr)
FR (1) FR8293M (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2392967A1 (fr) * 1977-04-21 1978-12-29 Lafon Labor Nouveaux derives d'acetamidoxime utiles notamment en therapeutique
EP1065931A1 (fr) * 1998-04-02 2001-01-10 Avicena Group, Inc. Compositions contenant de la creatine combinee a un second agent
WO2005117847A2 (fr) * 2004-06-02 2005-12-15 Combinatorx, Incorporated Methodes et composes de traitement de neoplasmes

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2392967A1 (fr) * 1977-04-21 1978-12-29 Lafon Labor Nouveaux derives d'acetamidoxime utiles notamment en therapeutique
EP1065931A1 (fr) * 1998-04-02 2001-01-10 Avicena Group, Inc. Compositions contenant de la creatine combinee a un second agent
EP1065931A4 (fr) * 1998-04-02 2006-10-11 Avicena Group Inc Compositions contenant de la creatine combinee a un second agent
WO2005117847A2 (fr) * 2004-06-02 2005-12-15 Combinatorx, Incorporated Methodes et composes de traitement de neoplasmes
WO2005117847A3 (fr) * 2004-06-02 2006-01-12 Combinatorx Inc Methodes et composes de traitement de neoplasmes

Also Published As

Publication number Publication date
DE1770537A1 (de) 1972-02-24

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
FR8293M (fr)
AU416737B2 (fr)
AU342066A (fr)
AU2977667A (fr)
AU3151267A (fr)
AU3189468A (fr)
AU610966A (fr)
AU1273466A (fr)
BE692409A (fr)
BE692198A (fr)
BE704025A (fr)
BE703856A (fr)
BE693070A (fr)
BE692922A (fr)
BE692780A (fr)
BE692779A (fr)
BE692778A (fr)
BE692654A (fr)
BE692577A (fr)
BE692553A (fr)
BE692552A (fr)
BE692493A (fr)
BE514578A (fr)
BE692375A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse